Management of malignant (necrotising) otitis externa.
Although malignant (necrotising) otitis externa is not a common diagnosis, there have been a number of recently reported cases with pathogens other than Pseudomonas aeruginosa as the causative organism. In addition, there are many published reports of resistance to antibiotics in cases of malignant otitis externa caused by Pseudomonas aeruginosa. This review aims to assess the cases reported and to clarify the current opinion on the diagnostic criteria and management of such cases.
ENT Department, Gloucestershire Royal Hospital, Gloucester, UK. sophie_hollis@hotmail.com
S
S
Hollis
K
K
Evans
D000890:Anti-Infective Agents / Q000627:therapeutic use*; D003920:Diabetes Mellitus / Q000453:epidemiology*; D003937:Diagnosis, Differential; D019468:Disease Management; D024881:Drug Resistance, Bacterial; D006801:Humans; D016867:Immunocompromised Host; D009336:Necrosis; D010032:Otitis Externa / Q000175:diagnosis / Q000453:epidemiology / Q000382:microbiology / Q000628:therapy*; D011552:Pseudomonas Infections / Q000150:complications* / Q000188:drug therapy; D011550:Pseudomonas aeruginosa / Q000187:drug effects / Q000302:isolation & purification*; D012720:Severity of Illness Index; D014057:Tomography, X-Ray Computed
D000890:Anti-Infective Agents